Safety Study of Whole Body Hyperthermia for Advanced Cancer
Not Applicable
Recruiting
- Conditions
- Advanced CancerPancreatic Cancer Metastatic
- Interventions
- Device: Whole body hyperthermiaDrug: Standard of Care (SOC) chemotherapy according to the NCCN guidelines.
- First Posted Date
- 2020-07-13
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- ElmediX
- Target Recruit Count
- 14
- Registration Number
- NCT04467593
- Locations
- 🇧🇪
University Hospital Antwerp, Edegem, Antwerpen, Belgium
© Copyright 2025. All Rights Reserved by MedPath